Back to top

Image: Bigstock

Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q4

Read MoreHide Full Article

The Chemours Company (CC - Free Report) reported a loss of $317 million or $1.94 per share in the fourth quarter of 2019 against a profit of $142 million or 81 cents per share a year ago.

Adjusted earnings were 56 cents per share for the quarter, which surpassed the Zacks Consensus Estimate of 43 cents.

Total revenues fell 7.6% year over year to $1,353 million, hurt by reduced volume and prices in the company’s Titanium Technologies and Fluoroproducts segments. Further, revenues lagged the Zacks Consensus Estimate of $1,370.1 million.

Segment Highlights

Revenues in the Fluoroproducts segment fell 5.4% year over year to $614 million in the reported quarter. The decline is attributable to weakness in the electronics and automotive markets as well as the ongoing impact of illegal imports of HFC refrigerants into the European Union.

Revenues in the Chemical Solutions unit were $129 million, down roughly 13% year over year. The company saw lower prices in the quarter mainly due to lower raw material prices.

Revenues in the Titanium Technologies division were $610 million, down 8.4% from the prior-year quarter. The decline is attributable to a lower volume of Ti-Pure titanium dioxide.

The Chemours Company Price, Consensus and EPS Surprise

 

2019 Highlights

For 2019, the company witnessed a loss of $52 million or 32 cents per share against a profit of $995 million or $5.45 per share recorded in 2018.

Revenues for the year declined 16.8% year over year to $5,526 million.

Financials

Chemours ended 2019 with cash and cash equivalents of $943 million, down 27.4% year over year. Long-term debt was $4,026 million, up 1.7% year over year.

Cash flows provided by operating activities were $400 million for the fourth quarter of 2019, up 54.4% year over year.

Outlook

For 2020, Chemours projects adjusted EBITDA of $1.05-$1.25 billion.

Capital expenditure for the year is anticipated to be approximately $400 million, while free cash flow is projected to be more than $350 million.

Adjusted earnings per share are forecast $2.60-$3.55 for 2020.

Price Performance

Chemours’ shares have lost 58.5% in the past year compared with the 26.4% decline recorded by its industry.

 

 

Zacks Rank & Stocks to Consider

Chemours currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the basic materials space are Daqo New Energy Corp. (DQ - Free Report) , Sandstorm Gold Ltd (SAND - Free Report) and Commercial Metals Company (CMC - Free Report) .

Daqo New Energy has a projected earnings growth rate of 326.3% for 2020. The company’s shares have rallied 133.1% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Sandstorm Gold has an estimated earnings growth rate of 166.7% for fiscal 2020. It currently flaunts a Zacks Rank #1. The company’s shares have rallied 25.7% in a year.

Commercial Metals has a Zacks Rank #2 (Buy) and a projected earnings growth rate of 20.2% for 2020. The company’s shares have rallied 32.7% in a year.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>